The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. (Annals of oncology : official journal of the European Society for Medical Oncology / ESMO, 2013)

(untitled) - Huijbers, A; Tollenaar, R; v Pelt, G; Zeestraten, E; Dutton, S; McConkey, C; Domingo, E; Smit, V; Midgley, R; Warren, B; Johnstone, E; Kerr, D; et al.